家族性颅内动脉瘤谜团的遗传学见解
本文综述家族性颅内动脉瘤(FIAs)的遗传与分子机制研究进展,聚焦关键遗传风险因素与环境影响。文章探讨全基因组关联研究和下一代测序技术发现的易感基因如ANGPTL6、肽基脯氨酰顺反异构酶样蛋白4和NOTCH3在FIA病理生理中的关键作用,并整合多组学与基因编辑研究成果,强调改进筛查、预防策略和治疗方法的潜力。
要点
- FIAs具有显著遗传易感性,家族内聚集且动脉瘤破裂后蛛网膜下腔出血风险增高。
- 全基因组关联研究和下一代测序技术已识别ANGPTL6、肽基脯氨酰顺反异构酶样蛋白4和NOTCH3等FIA易感基因。
- 多组学与基因编辑研究为改进FIA筛查、预防策略和治疗方法提供了潜在方向。
核心结论
- 对FIA遗传和分子机制的新见解对于推进FIA管理的精准医学至关重要,为协作研究和靶向干预铺平道路。
研究设计与样本
- 综述,分析关于家族性颅内动脉瘤遗传和分子机制的最新进展,聚焦关键遗传风险因素和环境影�响。
主要发现
- 全基因组关联研究和下一代测序技术已识别ANGPTL6、肽基脯氨酰顺反异构酶样蛋白4和NOTCH3作为FIA病理生理的关键贡献者。
- 整合多组学和基因编辑研究结果,凸显了改进筛查、预防策略和治疗方法的潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Familial intracranial aneurysms (FIAs) are distinguished by significant genetic predisposition, leading to clustering of cases within families and heightening the risk of subarachnoid hemorrhage following aneurysm rupture. This review analyzes recent advancements in understanding the genetic and molecular mechanisms underlying FIAs, focusing on key genetic risk factors and environmental influences. We explore cutting-edge genome-wide association studies and next-generation sequencing technologies, which have identified susceptibility genes such as ANGPTL6, peptidyl proline cis-trans isomerase like protein 4, and NOTCH3 as crucial contributors to FIA pathophysiology. By incorporating findings from multiomics and gene-editing research, we highlight the potential for improved screening, preventive strategies, and therapeutic approaches. These insights are essential to advancing precision medicine in managing FIAs, paving the way for collaborative research and targeted interventions.
引用
- Abulizi A, Su R, Wu P, et al. Genetic Insights into the Enigma of Family Intracranial Aneurysms. World Neurosurg. 2024. PMID: 39481842. doi:10.1016/j.wneu.2024.10.090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。